Major drugs company Pfizer has agreed to buy Illinois-based Hospira, which is a major manufacturer of injectable drugs, infusion technologies, and biosimilars, for $90 a share. This represents the first major acquisition for Pfizer after its attempt ... Digital Journal, 1 month ago
Why Pfizer's $17 Billion Buyout of Hospira is a Super-Smart Move - Citybizlist, 1 month ago
US Pharma Giant Pfizer Takes Over (Dollar) 17 Billion Hospira - 24Dunia, 1 month ago
Source: Wikimedia. Nearly all big pharma these days have been undergoing wholesale changes due to the patent cliff, the emergence of game-changing new classes of drugs, and payers leveraging their formularies to induce pricing wars. A direct ...Nasdaq, 1 week ago Pfizer Says Phase 4 Lyrica Study Fails To Meet Main Goal RTTNews.com, 2 weeks ago Did Pfizer Inc. Just Gut Its Chances of Finding New Blockbusters? Motley Fool, 2 weeks ago Pfizer developing PCSK9 pill, vaccine to lower cholesterol Reuters, 2 months ago
Pharmaceutical giant Pfizer, Inc. (PFE: Quote) revealed in a regulatory filing on Thursday that Chairman and Chief Executive Officer Ian Read received a 2014 total compensation that grew 23 percent from last year, reflecting strong increase in ...RTTNews.com, 2 weeks ago Hospira CEO May Walk Away With More Than $80 Million After Pfizer Deal is Finalized BioSpace, 1 month ago Pfizer Not Done With Deals Even After Hospira Purchase: Real M La Repubblica, 1 month ago Hospira may be just the tip of the iceberg for deal-hungry Pfizer FiercePharma, 1 month ago
US drugmaker Pfizer has received expanded approval from the European Commission (EC) for its Prevenar 13 (pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed), to prevent pneumonia caused by the 13 pneumococcal serotypes in the ...Pharmaceutical Technology, 3 weeks ago Pfizer planning R&D job cuts in response to "shifting priorities" FirstWord Pharma, 1 month ago Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 billion Reuters, 2 months ago MSF slams expensive vaccines, urges GSK and Pfizer to cut prices Reuters, 2 months ago
More from: , First Post.com...and 1 other sources
Pfizer Inc. (PFE) Strikes A $5 Billion Accelerated Share Repurchase Deal With Goldman Sachs Group Inc
Pfizer Inc. ( NYSE:PFE ) announced it has entered into an accelerated share repurchase (ASR) agreement with Goldman, Sachs & Co. to buy back $5 billion worth of the company's common stock. This repurchase decision is part of the company's ASR ...Bidness Etc, 1 month ago Pfizer Entered Into $5 Bln Accelerated Share Repurchase Agreement RTTNews.com, 1 month ago
REUTERS: Drugmaker Pfizer Inc said it entered into an agreement with Goldman, Sachs & Co to buy back US$5 billion of its stock. Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month. ...Channel NewsAsia, 1 month ago Pfizer in $5 bln accelerated buyback deal with Goldman, Sachs & Co CNBC, 1 month ago Pfizer in US$5 billion accelerated buyback deal with Goldman, Sachs & Co Channel NewsAsia, 1 month ago Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co Yahoo! UK and Ireland, 1 month ago
PFIZER : Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Pfizer...
Block & Leviton LLP Investigates Hospira, Inc. for Possible Breaches of Fiduciary Duty in Connection with Their Proposed Acquisition by Pfizer Inc. By a News Reporter-Staff News Editor at Biotech Week -- Block & Leviton LLP (www.blockesq.com), a ...4 Traders, 1 month ago Pfizer Pays A Pretty Penny For Hospira: Here's What You Need To Know Seeking Alpha, 1 month ago Pfizer To Buy Hospira For $15.23 Bln RTTNews.com, 1 month ago Hospira : UPDATE: Pfizer Inc To Buy Hospira Inc For USD15.23 Billion 4 Traders, 1 month ago
The pharma giant's stock is seemingly stuck in a rut, largely because of the loss of exclusivity for former top sellers such as Celebrex and Lipitor. But the truth is slightly more complex. Pfizer has been churning out major new products such as ...Motley Fool, 1 month ago Pfizer Flexes Muscle With Priciest Purchase of Decade Yahoo! Finance, 1 month ago
Pfizer's vote of confidence in biosimilars -- the generic alternatives to biologic-based medicines such as AbbVie's megablockbuster drug Humira -- isn't misplaced. According to Frost & Sullivan, the biosimilar market is expected to surge from just ...Motley Fool, 1 month ago
After being spurned repeatedly by British drugmaker AstraZeneca, Pfizer recently anted up $17 billion for a much smaller drug company, Hospira (NYSE: HSP While the acquisition surprised almost everyone, I think it's a savvy move. Hospira will allow ...Motley Fool, 1 month ago
on your WebpageAdd Widget >Get your members hooked!